⌘K

Login Start Free

Home/Filings/4/0001171843-12-001173

4//SEC Filing

Hohn David C 4

Accession 0001171843-12-001173

CIK 0001318641other

View on SEC.gov Company Profile

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 6:10 AM ET

Size

4.5 KB

Accession

0001171843-12-001173

Insider Transaction Report

Form 4

Period: 2012-04-04

CLEVELAND BIOLABS INCCBLI

Director

Transactions

Purchase
Common Stock, par value $0.005 per share
2012-04-04$1.71/sh+1,000$1,710→ 3,000 total

Footnotes (1)

[F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2011.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1

filerCIK 0001523106

Filing Metadata

Form type: 4
Filed: Apr 5, 8:00 PM ET
Accepted: Apr 6, 6:10 AM ET
Size: 4.5 KB

View on SEC.gov